Candel Therapeutics Inc CADL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
8.90quote price arrow down-0.12 (-1.33%)
Volume
9,777
Close
9.02quote price arrow up+0.59 (+7.00%)
Volume
987,338
52 week range
0.66 - 11.40
Loading...
  • Open8.34
  • Day High9.39
  • Day Low8.34
  • Prev Close8.43
  • 52 Week High11.40
  • 52 Week High Date04/05/24
  • 52 Week Low0.66
  • 52 Week Low Date11/03/23

Key Stats

  • Market Cap264.714M
  • Shares Out29.35M
  • 10 Day Average Volume0.73M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change513.61

KEY STATS

  • Open8.34
  • Day High9.39
  • Day Low8.34
  • Prev Close8.43
  • 52 Week High11.40
  • 52 Week High Date04/05/24
  • 52 Week Low0.66
  • 52 Week Low Date11/03/23
  • Market Cap264.714M
  • Shares Out29.35M
  • 10 Day Average Volume0.73M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change513.61

RATIOS/PROFITABILITY

  • EPS (TTM)-1.31
  • P/E (TTM)-6.88
  • Fwd P/E (NTM)-56.38
  • EBITDA (TTM)-37.031M
  • ROE (TTM)-125.50%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-102,990.30%
  • Debt To Equity (MRQ)166.94%

EVENTS

  • Earnings Date05/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Candel Therapeutics Inc

 

Profile

MORE
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the...
Paul Manning
Independent Chairman of the Board
Paul Tak M.D., Ph.D.
President, Chief Executive Officer, Director
Charles Schoch
Interim Chief Financial Officer
Christopher Matheny Pharm.D.
Vice President - Development Leader
Address
117 Kendrick Street,, Suite 450
Needham, MA
02494
United States

Top Peers

SYMBOLLASTCHG%CHG
ABOS
Acumen Pharmaceuticals Inc
3.49+0.01+0.29%
TRVI
Trevi Therapeutics Inc
3.02+0.01+0.33%
ATOS
Atossa Therapeutics Inc
1.66+0.14+9.21%
INO
Inovio Pharmaceuticals Inc
12.10+0.09+0.75%
LENZ
LENZ Therapeutics Inc
16.46+0.05+0.30%